BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 19935868)

  • 1. Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein.
    Fletcher S; Drewry JA; Shahani VM; Page BD; Gunning PT
    Biochem Cell Biol; 2009 Dec; 87(6):825-33. PubMed ID: 19935868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting aberrant Stat3 function with molecular therapeutics: a progress report.
    Haftchenary S; Avadisian M; Gunning PT
    Anticancer Drugs; 2011 Feb; 22(2):115-27. PubMed ID: 21063201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell death.
    Borghouts C; Tittmann H; Delis N; Kirchenbauer M; Brill B; Groner B
    Mol Cancer Res; 2010 Apr; 8(4):539-53. PubMed ID: 20371673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling.
    Jenkins BJ; Grail D; Nheu T; Najdovska M; Wang B; Waring P; Inglese M; McLoughlin RM; Jones SA; Topley N; Baumann H; Judd LM; Giraud AS; Boussioutas A; Zhu HJ; Ernst M
    Nat Med; 2005 Aug; 11(8):845-52. PubMed ID: 16041381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants governing the potency of STAT3 activation via the individual STAT3-recruiting motifs of gp130.
    Lehmann U; Sommer U; Smyczek T; Hörtner M; Frisch W; Volkmer-Engert R; Heinrich PC; Schaper F; Haan S
    Cell Signal; 2006 Jan; 18(1):40-9. PubMed ID: 15927449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.
    Leslie K; Lang C; Devgan G; Azare J; Berishaj M; Gerald W; Kim YB; Paz K; Darnell JE; Albanese C; Sakamaki T; Pestell R; Bromberg J
    Cancer Res; 2006 Mar; 66(5):2544-52. PubMed ID: 16510571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis.
    Rosen DG; Mercado-Uribe I; Yang G; Bast RC; Amin HM; Lai R; Liu J
    Cancer; 2006 Dec; 107(11):2730-40. PubMed ID: 17063503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution.
    Aggarwal BB; Sethi G; Ahn KS; Sandur SK; Pandey MK; Kunnumakkara AB; Sung B; Ichikawa H
    Ann N Y Acad Sci; 2006 Dec; 1091():151-69. PubMed ID: 17341611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor.
    Alvarez JV; Greulich H; Sellers WR; Meyerson M; Frank DA
    Cancer Res; 2006 Mar; 66(6):3162-8. PubMed ID: 16540667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell density dependent increase of constitutive signal transducers and activators of transcription 3 activity in melanoma cells is mediated by Janus kinases.
    Kreis S; Munz GA; Haan S; Heinrich PC; Behrmann I
    Mol Cancer Res; 2007 Dec; 5(12):1331-41. PubMed ID: 18171991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer.
    Dalwadi H; Krysan K; Heuze-Vourc'h N; Dohadwala M; Elashoff D; Sharma S; Cacalano N; Lichtenstein A; Dubinett S
    Clin Cancer Res; 2005 Nov; 11(21):7674-82. PubMed ID: 16278387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
    Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond structure, to survival: activation of Stat3 by cadherin engagement.
    Raptis L; Arulanandam R; Vultur A; Geletu M; Chevalier S; Feracci H
    Biochem Cell Biol; 2009 Dec; 87(6):835-43. PubMed ID: 19935869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cells.
    Duan Z; Bradner J; Greenberg E; Mazitschek R; Foster R; Mahoney J; Seiden MV
    Mol Pharmacol; 2007 Nov; 72(5):1137-45. PubMed ID: 17675586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor-induced ovarian carcinoma cell migration is associated with JAK2/STAT3 signals and changes in the abundance and localization of alpha6beta1 integrin.
    Colomiere M; Findlay J; Ackland L; Ahmed N
    Int J Biochem Cell Biol; 2009 May; 41(5):1034-45. PubMed ID: 18930836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of signal transducer and activator of transcription 3 activities by p53 tumor suppressor in breast cancer cells.
    Lin J; Jin X; Rothman K; Lin HJ; Tang H; Burke W
    Cancer Res; 2002 Jan; 62(2):376-80. PubMed ID: 11809683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical and functional interactions between STAT3 and ZIP kinase.
    Sato N; Kawai T; Sugiyama K; Muromoto R; Imoto S; Sekine Y; Ishida M; Akira S; Matsuda T
    Int Immunol; 2005 Dec; 17(12):1543-52. PubMed ID: 16219639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The STAT3 oncogene as a predictive marker of drug resistance.
    Barré B; Vigneron A; Perkins N; Roninson IB; Gamelin E; Coqueret O
    Trends Mol Med; 2007 Jan; 13(1):4-11. PubMed ID: 17118707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis.
    Bollrath J; Phesse TJ; von Burstin VA; Putoczki T; Bennecke M; Bateman T; Nebelsiek T; Lundgren-May T; Canli O; Schwitalla S; Matthews V; Schmid RM; Kirchner T; Arkan MC; Ernst M; Greten FR
    Cancer Cell; 2009 Feb; 15(2):91-102. PubMed ID: 19185844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT proteins: novel molecular targets for cancer drug discovery.
    Turkson J; Jove R
    Oncogene; 2000 Dec; 19(56):6613-26. PubMed ID: 11426647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.